Insights into the leveraging of GABAergic signaling in cancer therapy
Open Access
- 18 May 2023
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 12 (13) , 14498-14510
Abstract
Gamma‐aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain of adult mammals. Several studies have demonstrated that the GABAergic system may regulate tumor development via GABA receptors, downstream cyclic adenosine monophosphate (cAMP) pathway, epithelial growth factor receptor (EGFR) pathway, AKT pathway, mitogen‐activated protein kinase (MAPK) or extracellular signal‐related kinases (ERK) pathway, and matrix metalloproteinase (MMP) pathway, although the exact mechanism is unclear. Pioneering studies reported that GABA signaling exists and functions in the cancer microenvironment and has an immunosuppressive effect that contributes to metastasis and colonization. This article reviews the molecular structures and biological functions of GABAergic components correlated with carcinogenesis, the mechanisms underlying GABAergic signaling that manipulate the proliferation and invasion of cancer cells, and the potential GABA receptor agonists and antagonists for cancer therapy. These molecules may provide an avenue for the development of specific pharmacological components to prevent the growth and metastasis of various cancers.Keywords
Funding Information
- National Natural Science Foundation of China (82073000, 82173326)
- Natural Science Foundation of Sichuan Province (2022NSFSC0687, 2022YFS0289)
This publication has 107 references indexed in Scilit:
- GABA exerts protective and regenerative effects on islet beta cells and reverses diabetesProceedings of the National Academy of Sciences, 2011
- Inhibitory role for GABA in autoimmune inflammationProceedings of the National Academy of Sciences, 2010
- Propofol inhibits pressure-stimulated macrophage phagocytosis via the GABAA receptor and dysregulation of p130cas phosphorylationAmerican Journal of Physiology-Cell Physiology, 2009
- Ionotropic GABA receptor expression in the lung during developmentGene Expression Patterns, 2008
- Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinomaCarcinogenesis, 2008
- GABAB receptor is a novel drug target for pancreatic cancerCancer, 2008
- Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancerActa Oncologica, 2008
- Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancersProceedings of the National Academy of Sciences, 2006
- Is there more to gaba than synaptic inhibition?Nature Reviews Neuroscience, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002